NCT04981769View on ClinicalTrials.gov

POC SARS-CoV-2 Diagnostic PCR Device Comparison to FDA Approved Reference PCR Test

UnknownOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

August 2, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

November 30, 2021

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

Covid-19 test

PCR Covid-19 test

Sponsors
All Listed Sponsors
lead

Anavasi Diagnostics

INDUSTRY

NCT04981769 - POC SARS-CoV-2 Diagnostic PCR Device Comparison to FDA Approved Reference PCR Test | Biotech Hunter | Biotech Hunter